XTLB
XTL Biopharmaceuticals
XTLB
XTLB
6 hedge funds and large institutions have $687K invested in XTL Biopharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and closing their positions.
Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$26K |
| 2 |
2
Morgan Stanley
New York
|
$49K |
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$5K |
| 2 |
NI
2
Noked Israel
Ramat Hasharon,
Israel
|
$286K |
| 3 |
NC
3
Noked Capital
Tel Aviv,
Israel
|
$286K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NI
1
Noked Israel
Ramat Hasharon,
Israel
| $286K | 198,888 | -1 | -0% |
|
|
NC
2
Noked Capital
Tel Aviv,
Israel
| $286K | 198,888 | -1 | -0% |
|
|
3
Morgan Stanley
New York
| $49K | 36,132 | +100 | +0.3% |
|
4
Invesco
Atlanta,
Georgia
| $35K | 25,961 | – | – |
|
|
5
Citadel Advisors
Miami,
Florida
| $26K | 18,254 | +18,254 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| $5K | 3,328 | -200 | -6% |
|
|
CFGS
7
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|